Atherothrombosis and the management of the vulnerable vascular patient

American Journal of Therapeutics

Volumn 16, Issue 1, 2009, Pages 24-34

  Arora, Rohit ^a,b   Rai, Jhasi ^a  

^a The Chicago Medical College   (United States)

^b 3001 ^*  (United States)

Author keywords

Antiplatelets; Atherothrombosis; Vascular disease

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; NITRATE; PLACEBO;

ABDOMINAL PAIN; ADD ON THERAPY; ARTERY DISEASE; ATHEROSCLEROSIS; ATHEROTHROMBOSIS; BRAIN HEMORRHAGE; CLAUDICATION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DUODENUM ULCER; DYSPEPSIA; FEVER; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; HUMAN; INFECTION; ISCHEMIC HEART DISEASE; LOADING DRUG DOSE; PATHOPHYSIOLOGY; PEPTIC ULCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRURITUS; PURPURA; RASH; RECOMMENDED DRUG DOSE; REVIEW; STOMACH ULCER; UNSTABLE ANGINA PECTORIS; VASCULAR DISEASE;

ADULT; ASPIRIN; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; GUIDELINE ADHERENCE; HOSPITAL MORTALITY; HUMANS; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; REGISTRIES; RISK FACTORS; THROMBOSIS; TICLOPIDINE; UNITED STATES;

EID: 60249094623     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e318032587d     Document Type: Review

References (47)

1. Munger MA, Hawkins DW. Atherothrombosis: epidemiology, pathophysiology, and prevention. J Am Pharm Assoc. 2004;44(Suppl 1):S5-S13.
2. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005;111:3481-3488.
3. Fuster V, Fayad ZA, Moreno PR, et al. Atherothrombosis and high-risk plaque: part II: approaches by noninvasive computed tomographic/magnetic resonance imaging. J Am Coll Cardiol. 2005;46:1209-1218.
4. Bhatt DL. Diffuse coronary disease and atherothrombosis: a rationale for long-term therapy to prevent recurrent ischemic events. J Invasive Cardiol. 2003;15(Suppl B):3B-10B.
5. Goldstein JA, Demetriou D, Grines CL, et al. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med. 2000;343:915-922.
6. Zairis MN, Papadaki OA, Manousakis SJ, et al. C-reactive protein and multiple complex coronary artery plaques in patients with primary unstable angina. Atherosclerosis. 2002;164:355-359.
7. Rioufol G, Finet G, Ginon I, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a threevessel intravascular ultrasound study. Circulation. 2002;106:804-808.
8. Asakura M, Ueda Y, Yamaguchi O, et al. Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study. J Am Coll Cardiol. 2001;37:1284-1288.
9. Heart Disease and Stroke Statistics - 2006 Update. Dallas, TX: American Heart Association; 2006.
10. Hardie K, Hankey GJ, Jamrozik K, et al. Ten-year survival after first-ever stroke in the Perth Community Stroke Study. Stroke. 2003;34:1842-1846.
11. Taneja AK, Collinson J, Flather MD, et al. Mortality following non-ST elevation acute coronary syndrome: 4 years follow-up of the PRAIS UK Registry (Prospective Registry of Acute Ischaemic Syndromes in the UK). Eur Heart J. 2004;25:2013-2018.
12. Bakhai A. The burden of coronary, cerebrovascular and peripheral arterial disease. Pharmacoeconomics. 2004;22(Suppl 4):11-18.
13. Heart Disease and Stroke Statistics - 2006 Update. Dallas, TX: American Heart Association; 2006.
14. Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295:180-189.
15. Steg PG, Bhatt DL, Wilson PW, et al. 1-Year Cardiovascular Even Rates in a Global Contemporary Registry of Over 68,000 Outpatients with Atherothrombosis: The Reduction of Athero thrombosis for Continued Health (REACH) Registry Results. Presented at the American College of Cardiology; May 12, 2006; Atlanta, GA.
16. Heart Disease and Stroke Statistics - 2006 Update. Dallas, TX: American Heart Association; 2006.
17. Cannon CP. Critical pathway for unstable angina and non-ST elevation myocardial infarction. Critical Pathways in Cardiology. 2002;1:12-21.
18. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II. Circulation. 2003;108:1772-1778.
19. Ambrose JA, Martinez EE. A new paradigm for plaque stabilization. Circulation. 2002;105:2000-2004.
20. Armstrong PW, Fu Y, Chang WC, et al; for the GUSTO-IIb Investigators. Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators. Circulation. 1998;98:1860-1868.
21. Heart Disease and Stroke Statistics-2006 Update. Dallas, TX: American Heart Association; 2006.
22. Creager M, ed. Management of Peripheral Arterial Disease. Medical, Surgical and Interventional Aspects. London: ReMEDICA Publishing Limited; 2000.
23. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease [Lower Extremity, Renal Mesenteric, and Abdominal Aortic]). Available at: www.acc.org/clinical/guidelines/pad/ summary.pdf. Accessed January 23, 2006.
24. ACC/AHA guidelines for the management of patients with peripheral arterial disease. Available at: http://www.acc.org/clinical/guidelines/pad/ summary.pdf. Accessed January 23, 2006.
25. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26:3333-3341.
26. Beckman JA, Higgins CO, Gerhard-Herman M. Automated oscillometric determination of the ankle-brachial index provides accuracy necessary for office practice. Hypertension. 2006;47:35-38.
27. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). J Vase Surg. 2000;31:S1-S296.
28. Caro J, Migliaccio-Walle K, Ishak KJ, Proskorovsky I. The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database. BMC Cardiovasc Disord. 2005:5;14-21.
29. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary of the third Report of the National Cholesterol Education Program (NCEP). JAMA. 2001;285:2486-2497.
30. Kempczinski RF, Bernhard VM. Introduction and general considerations. In: Rutherford RB, ed. Vascular Surgery. Philadelphia: WB Saunders; 1989.
31. Clagett GP, Krupski WC. Antithrombotic therapy in peripheral arterial occlusive disease. Chest. 1995;108(Suppl 4):431S-443S.
32. McDermott MM, McCarthy W. Intermittent claudication: the natural history. Surg Clin North Am. 1995;75:581-591.
33. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339.
34. CURE Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502.
35. Plavix® (clopidogrel bisulfate) Prescribing Information. New York: Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership. Accessed at http://products.sanofi-aventis.us/plavix/plavix.html.
36. Data on file. Bridgewater, NJ: Sanofi Synthelabo Inc.
37. Braunwald E, Antman EM, Beasley JW, et al; American College of Cardiology; American Heart Association Committee on the Management of Patients With Unstable Angina. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). 2002. Available at: www.acc.org or http:/ / www.americanheart.org. Accessed January 3, 2006.
38. Braunwald E, Antman EM, Beasley JW, et al; American College of Cardiology; American Heart Association Committee on the Management of Patients With Unstable Angina. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). 2002. Available at: http://www.acc.org or www.americanheart.org. Accessed February 18, 2004.
39. Hirsch AT, Haskal ZJ, Hertzer NR, et al; American Association for Vascular Surgery; Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease; American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; Vascular Disease Foundation. ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease [Lower Extremity, Renal Mesenteric, and Abdominal Aortic]). Available at: www.acc.org/clinical/guidelines/pad/summary. pdf. Accessed January 7, 2006.
40. Hirsch AT, Haskal ZJ, Hertzer NR, et al; American Association for Vascular Surgery; Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease; American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlanric Inter-Society Consensus; Vascular Disease Foundation. ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary. Available at: www.acc.org. Accessed December 7, 2005.
41. Albers GW, Amarenco P, Easton JD, et al. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest. 2004; 126(Suppl):483S-511S.
42. Hanley D, Gorelick PB, Elliott WJ, et al. Determining the appropriateness of selected surgical and medical management options in recurrent stroke prevention: a guideline for primary care physicians from the National Stroke Association Work Group on Recurrent Stroke Prevention. J Stroke Cerebrovasc Dis. 2004;13:196-207.
43. Hoekstra JW, Pollack CV Jr, Roe MT, et al. Improving the care of patients with non-ST-elevation acute coronary syndromes in the emergency department: the CRUSADE initiative. Acad Emerg Med. 2002;9:1146-1155.
44. Duke Clinical Research Initiative. CRUSADE overview. Available at: www.crusadeqi.com. Accessed December16, 2005.
45. Duke Clinical Research Initiative. CRUSADE data, quarter 3, 2005. Available at: www.crusadeqi.com. Accessed December 17, 2005.
46. Braunwald E, Antman EM, Beasley JW, et al; American College of Cardiology; American Heart Association Committee on the Management of Patients With Unstable Angina. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). 2002. Available at: www.acc.org or http://www. americanheart.org. Accessed December 13, 2005.
47. Duke Clinical Research Initiative. CRUSADE data, quarter 3, 2005. Available at: www.crusadeqi.com. Accessed December 17, 2005.